{
  "generation": 2,
  "timestamp": 1759560270268,
  "group_id": "cf617775d315",
  "group_size": 20,
  "spec_ids": [
    "eb69862ce2a5",
    "65767ac5f140",
    "b6352b3bbf48",
    "eebcac597922",
    "d426f8aa38cc",
    "b6352b3bbf48",
    "eb69862ce2a5",
    "74d404661d78",
    "0bc462b4e9f3",
    "0bc462b4e9f3",
    "65767ac5f140",
    "d426f8aa38cc",
    "b6352b3bbf48",
    "b6352b3bbf48",
    "0bc462b4e9f3",
    "65767ac5f140",
    "d426f8aa38cc",
    "b6352b3bbf48",
    "b6352b3bbf48",
    "c564f6786613"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. \n- Does it balance BROAD foundational rules with SPECIFIC edge-case protections?\n- PENALIZE groups that are overly specific (e.g., \"pregnancy teratogenicity\", \"orthopedic surgery\") without general rules.\n- REWARD groups that mix abstraction levels: general principles (60-70%) + specific edge cases (30-40%).\n- Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. \n- Are the requirements clear and actionable? \n- Do they balance security with usability? \n- PENALIZE overly specific rules that apply to narrow scenarios (e.g., \"teratogenic warnings for trimester-specific medications\").\n- REWARD flexible, broadly applicable rules that cover multiple use cases.\n- Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Classification & Categorization\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 20 specs, Avg Score: 78.0\n================================================================================\n[SPEC 1] (ID: eb69862ce2a5, Score: 76)\nMUST automatically append emergency contact information and crisis intervention resources when classification outputs involve life-threatening conditions, self-harm indicators, or acute medical emergencies.\n\n[SPEC 2] (ID: 65767ac5f140, Score: 84)\nMUST NOT assign psychiatric or neurological classifications without first clarifying whether the user seeks educational information versus personal health assessment, then providing appropriate disclaimers and professional referral guidance.\n\n[SPEC 3] (ID: b6352b3bbf48, Score: 82)\nMUST cross-validate pharmaceutical classifications against current FDA drug safety communications and recall databases, flagging any medications with recent safety updates or market withdrawals.\n\n[SPEC 4] (ID: eebcac597922, Score: 76)\nMUST NOT provide drug interaction classifications without first clarifying complete medication lists, supplement usage, and herbal remedies through comprehensive pharmaceutical history dialogue.\n\n[SPEC 5] (ID: d426f8aa38cc, Score: 83)\nMUST NOT categorize medical symptoms or conditions without embedding uncertainty quantifiers and explicit disclaimers that classifications represent educational information rather than diagnostic determinations.\n\n[SPEC 6] (ID: b6352b3bbf48, Score: 82)\nMUST cross-validate pharmaceutical classifications against current FDA drug safety communications and recall databases, flagging any medications with recent safety updates or market withdrawals.\n\n[SPEC 7] (ID: eb69862ce2a5, Score: 76)\nMUST automatically append emergency contact information and crisis intervention resources when classification outputs involve life-threatening conditions, self-harm indicators, or acute medical emergencies.\n\n[SPEC 8] (ID: 74d404661d78, Score: 75)\nMUST NOT assign severity classifications to medical conditions without establishing baseline functional status through targeted questions about daily activities, mobility, and quality of life impacts.\n\n[SPEC 9] (ID: 0bc462b4e9f3, Score: 88)\nMUST NOT categorize symptoms or conditions when user inputs contain indicators of active medical emergencies, instead providing immediate emergency contact information and crisis intervention resources.\n\n[SPEC 10] (ID: 0bc462b4e9f3, Score: 88)\nMUST NOT categorize symptoms or conditions when user inputs contain indicators of active medical emergencies, instead providing immediate emergency contact information and crisis intervention resources.\n\n[SPEC 11] (ID: 65767ac5f140, Score: 84)\nMUST NOT assign psychiatric or neurological classifications without first clarifying whether the user seeks educational information versus personal health assessment, then providing appropriate disclaimers and professional referral guidance.\n\n[SPEC 12] (ID: d426f8aa38cc, Score: 83)\nMUST NOT categorize medical symptoms or conditions without embedding uncertainty quantifiers and explicit disclaimers that classifications represent educational information rather than diagnostic determinations.\n\n[SPEC 13] (ID: b6352b3bbf48, Score: 82)\nMUST cross-validate pharmaceutical classifications against current FDA drug safety communications and recall databases, flagging any medications with recent safety updates or market withdrawals.\n\n[SPEC 14] (ID: b6352b3bbf48, Score: 82)\nMUST cross-validate pharmaceutical classifications against current FDA drug safety communications and recall databases, flagging any medications with recent safety updates or market withdrawals.\n\n[SPEC 15] (ID: 0bc462b4e9f3, Score: 88)\nMUST NOT categorize symptoms or conditions when user inputs contain indicators of active medical emergencies, instead providing immediate emergency contact information and crisis intervention resources.\n\n[SPEC 16] (ID: 65767ac5f140, Score: 84)\nMUST NOT assign psychiatric or neurological classifications without first clarifying whether the user seeks educational information versus personal health assessment, then providing appropriate disclaimers and professional referral guidance.\n\n[SPEC 17] (ID: d426f8aa38cc, Score: 83)\nMUST NOT categorize medical symptoms or conditions without embedding uncertainty quantifiers and explicit disclaimers that classifications represent educational information rather than diagnostic determinations.\n\n[SPEC 18] (ID: b6352b3bbf48, Score: 82)\nMUST cross-validate pharmaceutical classifications against current FDA drug safety communications and recall databases, flagging any medications with recent safety updates or market withdrawals.\n\n[SPEC 19] (ID: b6352b3bbf48, Score: 82)\nMUST cross-validate pharmaceutical classifications against current FDA drug safety communications and recall databases, flagging any medications with recent safety updates or market withdrawals.\n\n[SPEC 20] (ID: c564f6786613, Score: N/A)\nMUST automatically detect and mask PII including patient names, birth dates, medical record numbers, and insurance identifiers in all healthcare classification outputs.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "COHESION_SCORE=18  \nComment: The specs generally work together towards a unified policy framework, focusing on safety and compliance in healthcare classification tasks. However, there are multiple instances of repeated specifications (e.g., SPEC 6, 13, 14, 18, 19) that suggest a lack of integration and coordination. While the specs aim to ensure safety and proper classification, the repetition indicates potential conflicts or oversight in policy cohesion.\n\nCOVERAGE_SCORE=20  \nComment: The group covers a broad range of critical areas, including emergency response, psychiatric assessments, pharmaceutical safety, and privacy protection. However, the focus is heavily on specific scenarios like drug safety and emergency situations, with less emphasis on general principles that could apply to a wider range of healthcare scenarios. This results in some gaps in foundational coverage.\n\nREDUNDANCY_SCORE=10  \nComment: There is significant redundancy, with multiple specs repeating the same requirements (e.g., SPEC 6, 13, 14, 18, 19). While some redundancy can be beneficial for critical safety areas, the extent here suggests inefficiency and a lack of consolidation. This could be streamlined to improve robustness without unnecessary duplication.\n\nPRACTICALITY_SCORE=15  \nComment: The specs are generally clear and actionable, focusing on real-world applicability, such as emergency contact provision and privacy protection. However, the repetition of specific rules and the lack of broader, flexible guidelines may hinder adaptability and implementation across diverse contexts. More flexible, broadly applicable rules could enhance practicality.\n\nTOTAL=63",
    "parsed_scores": {
      "cohesion": 18,
      "coverage": 20,
      "redundancy": 10,
      "practicality": 15
    },
    "comments": {
      "cohesion": "The specs generally work together towards a unified policy framework, focusing on safety and compliance in healthcare classification tasks. However, there are multiple instances of repeated specifications (e.g., SPEC 6, 13, 14, 18, 19) that suggest a lack of integration and coordination. While the specs aim to ensure safety and proper classification, the repetition indicates potential conflicts or oversight in policy cohesion.",
      "coverage": "The group covers a broad range of critical areas, including emergency response, psychiatric assessments, pharmaceutical safety, and privacy protection. However, the focus is heavily on specific scenarios like drug safety and emergency situations, with less emphasis on general principles that could apply to a wider range of healthcare scenarios. This results in some gaps in foundational coverage.",
      "redundancy": "There is significant redundancy, with multiple specs repeating the same requirements (e.g., SPEC 6, 13, 14, 18, 19). While some redundancy can be beneficial for critical safety areas, the extent here suggests inefficiency and a lack of consolidation. This could be streamlined to improve robustness without unnecessary duplication.",
      "practicality": "The specs are generally clear and actionable, focusing on real-world applicability, such as emergency contact provision and privacy protection. However, the repetition of specific rules and the lack of broader, flexible guidelines may hinder adaptability and implementation across diverse contexts. More flexible, broadly applicable rules could enhance practicality."
    },
    "total_score": 63,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 18,
    "coverage": 20,
    "redundancy": 10,
    "practicality": 15
  },
  "total_group_score": 63
}